Home
Astrazeneca Pharma India Ltd Share Price History
Astrazeneca Pharma India Ltd
NSE : 17 Apr, 2025
8746231.5 (2.7%)
Prev Close
8514.5
Open Price
8506.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
59344
Today's High / Low
8780.0 / 8505.0
52 WK High / Low
9167.5 / 4800.1
Market Price of Astrazeneca Pharma India Ltd
1M
1Y
3Y
5Y
Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 549 |
| Sales YoY Gr. | - |
| Adj EPS | 8.02 |
| YoY Gr. | - |
| Net Profit (Cr.) | 20 |
| BVPS | 89.15 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 14.17 |
| Op. Profit Mgn % | 7.98 |
| Net Profit Mgn % | 2.87 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Astrazeneca Pharma India Ltd
- AstraZeneca Pharma India (APIL) was incorporated on July 11, 1979.
- The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
- The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
- Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.
Popular Search
FAQs for Astrazeneca Pharma India Ltd Share Price History
What are the key events that typically impact Astrazeneca Pharma India Ltd's share price history?
Key events that impact Astrazeneca Pharma India Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Astrazeneca Pharma India Ltd's share price history?
Stock splits reduce the nominal price of Astrazeneca Pharma India Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Astrazeneca Pharma India Ltd?
Dividends can influence Astrazeneca Pharma India Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Astrazeneca Pharma India Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Astrazeneca Pharma India Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Astrazeneca Pharma India Ltd’s share price history?
To understand Astrazeneca Pharma India Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
